MORRISVILLE, N.C.--(BUSINESS WIRE)--Trimeris, Inc. (NASDAQ: TRMS) today announced financial results for the three months ended June 30, 2007, reporting total revenues of $9.1 million, an increase of 25 percent, compared to the same period last year. This increase was primarily driven by worldwide sales of FUZEON, which reached $62.0 million, a growth of 8 percent over the same period last year. All sales of FUZEON are recorded by F. Hoffmann-La Roche Ltd. (“Roche”), Trimeris’ collaborative partner.
